Literature DB >> 15956227

Use of the transtheoretical model in the medication use process.

Danielle L Ficke1, Karen B Farris.   

Abstract

OBJECTIVE: To review articles published during the past 10 years relating to the transtheoretical model (TTM) and the medication use process, focusing on prescribing, dispensing, and using prescription and nonprescription medications for legitimate purposes. DATA SOURCES: MEDLINE, Cochrane database, PsychINFO, International Pharmaceutical Abstracts, and PubMed were searched from 1995 to August 2004 using the key terms models, psychological; prescriptions, drug; drugs, nonprescription; models, theoretical; self medication; patient compliance; medication compliance; decision making; drug therapy and behavior change. Additional searches included the following terms: pharmacists, community; TTM; transtheoretical model, pharmacy services, new practice patterns and physician practice patterns. STUDY SELECTION AND DATA EXTRACTION: Studies with empirical application of any aspect of TTM were included. Abstracts were reviewed by both authors, and data were independently abstracted including, for example, specific aspects of TTM used or tested, context for model use or setting, and results and authors' suggestions for future use of TTM. The reviewers came to consensus on all abstracted information. DATA SYNTHESIS: Eleven articles were identified that contained TTM and drug use; however, only 5 were empirical applications. There were 2 types of applications of TTM in medication use: measurement of stage of change regarding adherence and prediction of adherence using TTM concepts. A 1- and 2-item measure of adherence stage of change have been validated. Medication adherence stage of change varied by type of drug. The pros and cons of taking the medicine and stage of change were useful in predicting adherence. No intervention studies to improve adherence were identified.
CONCLUSIONS: TTM has not been used extensively to examine the medication use process. Without further research, no clear recommendation can be provided as to the effectiveness of TTM in improving the drug use process, but it remains promising.

Entities:  

Mesh:

Year:  2005        PMID: 15956227     DOI: 10.1345/aph.1G122

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  4 in total

1.  Improving the physician-patient cardiovascular risk dialogue to improve statin adherence.

Authors:  Linda Casebeer; Craig Huber; Nancy Bennett; Rachael Shillman; Maziar Abdolrasulnia; Gregory D Salinas; Sijian Zhang
Journal:  BMC Fam Pract       Date:  2009-06-30       Impact factor: 2.497

2.  Smartphone medication adherence apps: potential benefits to patients and providers.

Authors:  Lindsey Dayer; Seth Heldenbrand; Paul Anderson; Paul O Gubbins; Bradley C Martin
Journal:  J Am Pharm Assoc (2003)       Date:  2013 Mar-Apr

3.  Reducing resistance to treatment, through group intervention, improves clinical measurements in patients with type 2 diabetes.

Authors:  Liora Valinsky; Moshe Mishali; Ronit Endevelt; Rachel Preiss; Keren Dopelt; Anthony D Heymann
Journal:  BMC Endocr Disord       Date:  2013-12-28       Impact factor: 2.763

4.  Developing a generic, individualised adherence programme for chronic medication users.

Authors:  Hanne Herborg; Lotte S Haugbølle; Lene Sørensen; Charlotte Rossing; Pernille Dam
Journal:  Pharm Pract (Granada)       Date:  2008-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.